UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Loss of Rassf1a enhances p53-mediated tumor predisposition and accelerates progression to aneuploidy

Oncogene, 2011-02, Vol.30 (6), p.690-700

2011

Volltextzugriff (PDF)

Tumor susceptibility of Rassf1a knockout mice

Cancer research (Chicago, Ill.), 2005-01, Vol.65 (1), p.92-98

2005

Volltextzugriff (PDF)

The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors

Cancer research (Chicago, Ill.), 2003-11, Vol.63 (21), p.7515-7519

2003

Volltextzugriff (PDF)

The accuracy of urinary cytology in daily practice

Cancer, 1999-06, Vol.87 (3), p.118-128

1999

Volltextzugriff (PDF)

Human papillomavirus (HPV) in head and neck cancer : An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring

Cancer, 1997-02, Vol.79 (3), p.595-604

1997

Volltextzugriff (PDF)

Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma

The American journal of pathology, 1998-01, Vol.152 (1), p.145-156

1998

Volltextzugriff (PDF)

Methylation of the RASSF1A Gene in Human Cancers

Biological chemistry, 2002-06, Vol.383 (6), p.907-914

2002

Volltextzugriff (PDF)

Early Stage Cervical Cancers Containing Human Papillomavirus Type 18 DNA Have More Nodal Metastasis and Deeper Stromal Invasion

Clinical cancer research, 2003-09, Vol.9 (11), p.4145-4150

2003

Volltextzugriff (PDF)

Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFR α, and PDGFR β in ovarian cancers

Human pathology, 2005-03, Vol.36 (3), p.242-249

2005

Volltextzugriff (PDF)

Inactivation of RAS Association Domain Family 1A gene in cervical carcinomas and the role of human papillomavirus infection

Cancer research (Chicago, Ill.), 2003-04, Vol.63 (8), p.1888-1893

2003

Volltextzugriff (PDF)

HPV infection and number of lifetime sexual partners are strong predictors for 'natural' regression of CIN 2 and 3

British journal of cancer, 2003-09, Vol.89 (6), p.1062-1066

2003

Volltextzugriff (PDF)

Combined Intraperitoneal and Intravenous Chemotherapy for Women With Optimally Debulked Ovarian Cancer: Results From an Intergroup Phase II Trial

Journal of clinical oncology, 2003-04, Vol.21 (7), p.1313-1319

2003

Volltextzugriff (PDF)

Human Papillomavirus Type 18: Association With Poor Prognosis in Early Stage Cervical Cancer

JNCI : Journal of the National Cancer Institute, 1996-10, Vol.88 (19), p.1361-1368

1996

Volltextzugriff (PDF)

Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: a phase II study of the Southwest Oncology Group

Gynecologic oncology, 2005-03, Vol.96 (3), p.610-615

2005

Volltextzugriff (PDF)

A Randomized, Double Blind, Phase III Trial Using Oral β-Carotene Supplementation for Women with High-Grade Cervical Intraepithelial Neoplasia

Cancer epidemiology, biomarkers & prevention, 2001-10, Vol.10 (10), p.1029-1035

2001

Volltextzugriff (PDF)

Prognostic significance of human papillomavirus DNA in vulvar carcinoma

Obstetrics and gynecology (New York. 1953), 1995-05, Vol.85 (5 Pt 1), p.709-715

1995

Volltextzugriff (PDF)

Enrichment for DNA mismatch repair‐deficient cells during treatment with cisplatin

International journal of cancer, 1998-08, Vol.77 (5), p.741-746

1998

Volltextzugriff (PDF)

Carcinoma of the vulva : HPV and p53 mutations

Oncogene, 1994-06, Vol.9 (6), p.1655-1659

1994

Volltextzugriff (PDF)

Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer

Oncogene, 2002-08, Vol.21 (36), p.5631-5642

2002

Volltextzugriff (PDF)

Randomized Phase II trial of two high-dose chemotherapy regimens with stem cell transplantation for the treatment of advanced ovarian cancer in first remission or chemosensitive relapse: a Southwest Oncology Group study

Gynecologic oncology, 2004-07, Vol.94 (1), p.98-106

2004

Volltextzugriff (PDF)

Uterine effects of tamoxifen: a prospective study

International journal of gynecological cancer, 2006-03, Vol.16 (2), p.814-820

2006

Volltextzugriff (PDF)

Mutations of p53 and human papillomavirus infection in cervical carcinoma

Cancer, 1993-08, Vol.72 (4), p.1272-1280

1993

Volltextzugriff (PDF)

Recurrence of pulmonary mucinous cystic tumor of borderline malignancy

The Annals of thoracic surgery, 2001-02, Vol.71 (2), p.696-697

2001

Volltextzugriff (PDF)

p53 mutations in HPV-negative cervical carcinoma

Oncogene, 1994, Vol.9 (1), p.205-210

1994

Volltextzugriff (PDF)

p53 Alterations in Uterine Leiomyosarcomas versus Leiomyomas

Gynecologic oncology, 1994-08, Vol.54 (2), p.205-208

1994

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(56)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Loss of Rassf1a enhances p53-mediated tumor predisposition and accelerates progression to aneuploidy

Tumor susceptibility of Rassf1a knockout mice

The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors

The accuracy of urinary cytology in daily practice

Human papillomavirus (HPV) in head and neck cancer : An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring

Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma

Methylation of the RASSF1A Gene in Human Cancers

Early Stage Cervical Cancers Containing Human Papillomavirus Type 18 DNA Have More Nodal Metastasis and Deeper Stromal Invasion

Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFR α, and PDGFR β in ovarian cancers

Inactivation of RAS Association Domain Family 1A gene in cervical carcinomas and the role of human papillomavirus infection

HPV infection and number of lifetime sexual partners are strong predictors for 'natural' regression of CIN 2 and 3

Combined Intraperitoneal and Intravenous Chemotherapy for Women With Optimally Debulked Ovarian Cancer: Results From an Intergroup Phase II Trial

Human Papillomavirus Type 18: Association With Poor Prognosis in Early Stage Cervical Cancer

Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: a phase II study of the Southwest Oncology Group

A Randomized, Double Blind, Phase III Trial Using Oral β-Carotene Supplementation for Women with High-Grade Cervical Intraepithelial Neoplasia

Prognostic significance of human papillomavirus DNA in vulvar carcinoma

Enrichment for DNA mismatch repair‐deficient cells during treatment with cisplatin

Carcinoma of the vulva : HPV and p53 mutations

Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer

Randomized Phase II trial of two high-dose chemotherapy regimens with stem cell transplantation for the treatment of advanced ovarian cancer in first remission or chemosensitive relapse: a Southwest Oncology Group study

Uterine effects of tamoxifen: a prospective study

Mutations of p53 and human papillomavirus infection in cervical carcinoma

Recurrence of pulmonary mucinous cystic tumor of borderline malignancy

p53 mutations in HPV-negative cervical carcinoma

p53 Alterations in Uterine Leiomyosarcomas versus Leiomyomas

Suchergebnisse filtern